According to an Ernst and Young report (2011) India and China have emerged as an important destination for outsourcing and offshoring by MNCs across the pharma value chain – from R&amp ...

All of this is putting new demands on the supply chain ... distribution. Pharma companies are increasingly relying on external partners for transportation, warehousing and other value-added ...

No matter how high the inflation is, their demand is inelastic. No matter how slow the current profit growth is, these ...

The core idea behind Pharma 4.0 is to leverage the advancements in digital technologies such as artificial intelligence (AI), machine learning (ML), big data, Internet of Things (IoT), automation, and ...

Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...

Belgium is capitalising on a radiopharmaceutical sector investment boom. Pharma giants are acquiring radioligand therapy ...

Indian pharma is focusing on strengthening post-marketing surveillance (PMS) and improving supply chain transparency for over-the-counter (OTC ... including $25 billion in prescription savings and $77 ...

The government aims to utilise land from closed pharma units for healthcare and education infrastructure in Telangana, West Bengal and Uttarakhand. It has roped in NIPER, a government-owned ...